Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

161
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
161
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

207
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
207
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

202
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
202
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

163
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
163
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

435
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
435
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

194
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
194

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Role of Various Commercial <i>Saccharomyces cerevisiae</i> in Secondary Fermentation of Pineapple Glutinous Rice Wine: Insights into Volatile Profiling by GC-IMS and Sensory Attributes.

Foods (Basel, Switzerland)·2026
Same author

Isolation, Identification, and Validation of Strains from Commercial Probiotics: Do We Get What We Expect?

Foods (Basel, Switzerland)·2026
Same author

Not Just an Aroma Compound: Expanding Perspectives on Diacetyl in Food Systems and Human Health.

Molecules (Basel, Switzerland)·2026
Same author

Bio-Functional Properties of Lactic Acid Bacteria in Functional Foods.

Foods (Basel, Switzerland)·2026
Same author

Seasonal Variation in the Mutagenic and Oxidative Properties of Gut Microbiota in Active and Hibernating Common Noctules (Nyctalus noctula).

Current microbiology·2026
Same author

Bacteriocins, a New Generation of Sustainable Alternatives to Antibacterial Agents in Primary Food Production Systems.

Molecules (Basel, Switzerland)·2026

相关实验视频

Updated: Jun 28, 2025

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:53

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

826

基于乳制品的乳酸细菌对便秘的抗衰老作用.

Mohamad Hafis Jaafar1, Pei Xu1,2, Uma-Mageswary Mageswaran1

  • 1Bioprocess Technology, School of Industrial Technology, Universiti Sains Malaysia, Penang 11800, Malaysia.

Journal of animal science and technology
|April 15, 2024
PubMed
概括

乳制品中分离的乳酸细菌 (LAB) 菌株改善了老老鼠的便秘. 这些益生菌软化了便和增加了水分,为与年龄相关的消化问题提供了潜在的饮食干预.

关键词:
衰老的衰老 衰老的衰老便秘 便秘 便秘 便秘乳制品食品 乳制品食品是一种乳制品.基于乳制品的乳酸细菌 (LAB)益生菌 益生菌 益生菌

更多相关视频

Measuring Lactase Enzymatic Activity in the Teaching Lab
04:41

Measuring Lactase Enzymatic Activity in the Teaching Lab

Published on: August 6, 2018

113.7K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.6K

相关实验视频

Last Updated: Jun 28, 2025

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:53

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

826
Measuring Lactase Enzymatic Activity in the Teaching Lab
04:41

Measuring Lactase Enzymatic Activity in the Teaching Lab

Published on: August 6, 2018

113.7K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.6K

科学领域:

  • 微生物学 微生物学
  • 胃肠病学 胃肠病学
  • 老年学是一门学科.

背景情况:

  • 便秘是老年动物和牲畜中常见的健康问题.
  • 老龄化会加剧排便困难和不经常排便.
  • 目前的治疗方法可能有局限性,需要采取替代干预措施.

研究的目的:

  • 评估乳制品中分离的乳酸细菌 (LAB) 菌株在老鼠模型中缓解便秘的疗效.
  • 探索LAB作为与年龄有关的便秘的潜在治疗干预措施.
  • 研究特定LAB菌株对便秘的生理和代谢标志物的影响.

主要方法:

  • 用D-银糖使老鼠变老,用洛佩拉米德化物诱导便秘.
  • 通过口腔口服 *乳杆菌发酵* USM 4189 或 *乳杆菌植物* USM 4187.
  • 评估便特征 (布里斯托尔便图,水分含量),便代谢物概况和结肠组织病理学.

主要成果:

  • 与对照组相比,LAB的使用导致便较软,便含水量增加.
  • 便分析显示,LAB.治疗的老鼠中,氨酸度降低.
  • 组织病理学检查显示,在LAB治疗组中,结肠杯细胞数量较高.

结论:

  • 乳制品来源的LAB菌株显示出作为益生菌改善与衰老相关的便秘的潜力.
  • 这些LAB菌株可以作为一种可行的饮食干预策略,特别是在酸奶和奶酪等乳制品中.
  • 需要对LAB进行进一步的研究,以控制与年龄相关的便秘.